rLP2086 (bivalent)

rLP2086 · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rLP2086 (bivalent), covering 2020-03-27 to 2020-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose [Phase 3]